Page 18 - AIH-1-1

Artificial Intelligence in Health AI in prostate cancer detection

3. Center MM, Jemal A, Lortet-Tieulent J, et al., 2012, https://doi.org/10.1056/NEJMoa1801993
International variation in prostate cancer incidence and 14. Rouvière O, Puech P, Renard-Penna R, et al., 2019, Use
mortality rates. Eur Urol, 61: 1079–1092. of prostate systematic and targeted biopsy on the basis of
https://doi.org/10.1016/j.eururo.2012.02.054 multiparametric MRI in biopsynaive patients (MRI-FIRST):
A prospective, multicentre, paired diagnostic study. Lancet
4. Rebbeck TR, Devesa SS, Chang BL, et al., 2013, Global
patterns of prostate cancer incidence, aggressiveness, and Oncol, 20: 100–109.
mortality in men of African descent. Prostate Cancer, https://doi.org/10.1016/S1470-2045(18)30569-2
2013: 560857. 15. Van der Leest M, Cornel E, Israël B, et al., 2019, Head-to-
https://doi.org/10.1155/2013/560857 head comparison of transrectal ultrasound-guided prostate
biopsy versus multiparametric prostate resonance imaging
5. Zhou CK, Check DP, Lortet-Tieulent J, et al., 2016, Prostate with subsequent magnetic resonance-guided biopsy in
cancer incidence in 43 populations worldwide: An analysis biopsy-naïve men with elevated prostate-specific antigen:
of time trends overall and by age group. Int J Cancer, A large prospective multicenter clinical study. Eur Urol,
138: 1388–1400. 75: 570–578.
https://doi.org/10.1002/ijc.29894 https://doi.org/10.1016/j.eururo.2018.11.023
6. World Cancer Research Fund/American Institute for Cancer 16. Mottet N, Bellmunt J, Bolla M, et al., 2017, EAU-ESTRO-
Research, 2018, Continuous Update Project Expert Report. SIOG guidelines on prostate cancer. Part 1: Screening,
Body Fatness and Weight Gain and the Risk of Cancer. diagnosis, and local treatment with curative intent. Eur Urol,
United Kingdom: World Cancer Research Fund. 71: 618–629.
7. Bray F, Pineros M, 2016, Cancer patterns, trends and https://doi.org/10.1016/j.eururo.2016.08.003
projections in Latin America and the Caribbean: A global
context. Salud Publica Mex, 58: 104–117. 17. Rosenkrantz AB, Ayoola A, Hoffman D, et al., 2017, The
learning curve in prostate MRI interpretation: Self-directed
https://doi.org/10.21149/spm.v58i2.7779 learning versus continual reader feedback. AJR Am J
8. Culp MB, Soerjomataram I, Efstathiou JA, et al., 2020, Roentgenol, 208: W92–W100.
Recent global patterns in prostate cancer incidence and https://doi.org/10.2214/AJR.16.16876
mortality rates. Eur Urol, 77: 38–52.
18. Tran BX, Latkin CA, Sharafeldin N, et al., 2019,
https://doi.org/10.1016/j.eururo.2019.08.005 Characterizing artificial intelligence applications in cancer
9. Seraphin TP, Joko-Fru WY, Kamate B, et al., 2020, Rising research: A latent dirichlet allocation analysis. JMIR Med
prostate cancer incidence in sub-Saharan Africa: A trend Inform, 7: e14401.
analysis of data from the African Cancer Registry Network. https://doi.org/10.2196/14401
Cancer Epidemiol Biomarkers Prev, 30:158–165.
19. Pantanowitz L, Quiroga-Garza GM, Bien L, et al., 2020, An
https://doi.org/10.1158/1055-9965.EPI-20-1005 artificial intelligence algorithm for prostate cancer diagnosis
10. Lin K, Lipsitz R, Janakiraman S, 2008, Benefits and harms of in whole slide images of core needle biopsies: A blinded
prostate-specific antigen screening for prostate cancer: An clinical validation and deployment study. Lancet Digit
evidence update for the U.S. Preventive Services Task Force. Health, 2: e407–e416.
Ann Intern Med, 149: 192–199. https://doi.org/10.1016/S2589-7500(20)30159-X
https://doi.org/10.7326/0003-4819-149-3-200808050-00009 20. Twilt JJ, van Leeuwen KG, Huisman HJ, et al., 2021,
11. Wolf AMD, Wender RC, Etzioni RB, et al., 2010, American Artificial intelligence based algorithms for prostate cancer
Cancer Society guideline for the early detection of prostate classification and detection on magnetic resonance imaging:
cancer: Update 2010. CA Cancer J Clin, 60: 70–98. A narrative review. Diagnostics (Basel), 11: 959.
https://doi.org/10.3322/caac.20066 https://doi.org/10.3390/diagnostics11060959
12. US Preventive Services Task Force, Grossman DC, Curry SJ, 21. Mata LA, Retamero JA, Gupta RT, et al., 2021, Artificial
et al., 2018, Screening for prostate cancer: US Preventive intelligence-assisted prostate cancer diagnosis: Radiologic-
Services Task Force recommendation statement. JAMA, pathologic correlation. Radiographics, 41: 1676–1697.
319: 1901–1913. https://doi.org/10.1148/rg.2021210020
https://doi.org/10.1001/jama.2018.3710 22. Guo Y, Hao Z, Zhao S, et al., 2020, Artificial intelligence
13. Kasivisvanathan V, Rannikko AS, Borghi M, et al., 2018, in health care: Bibliometric analysis. J Med Internet Res,
MRI-targeted or standard biopsy for prostate-cancer 22: e18228.
diagnosis. N Engl J Med, 378: 1767–1777. https://doi.org/10.2196/18228

Volume 1 Issue 1 (2024) 12 https://doi.org/10.36922/aih.1958